Apollomics (APLM) EBITDA Yield: History & Chart

Apollomics, Inc.(APLM)

Biotechnology · Foster City, CA

$22.46-0.81 (-3.46%)

Delayed quote: Oct 6, 2026, 1:30 PM EDT

About Apollomics, Inc.

Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.

Foster City, CA

14 employees

www.apollomicsinc.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Hung-Wen Chen

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Apollomics, Inc. (APLM)	$49.32M	N/A	N/A	N/A	N/A
TELA Bio, Inc. (TELA)vs ›	$49.21M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$49.45M	N/A	3.11%	2.71%	2.71%
Sensus Healthcare, Inc. (SRTS)vs ›	$49.55M	N/A	11.25%	14.93%	13.84%
Microbot Medical Inc. (MBOT)vs ›	$49.34M	N/A	0.89%	5.54%	4.70%
Dogwood Therapeutics, Inc. (DWTX)vs ›	$49.77M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$49.79M	N/A	N/A	N/A	N/A
Lite Strategy, Inc. (LITS)vs ›	$48.32M	N/A	N/A	N/A	N/A
Precision Optics Corporation, Inc. (POCI)vs ›	$48.27M	N/A	0.84%	0.84%	0.84%
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$50.45M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Apollomics, Inc. (APLM)

$49.32M

N/A

TELA Bio, Inc. (TELA)vs ›

$49.21M

N/A

INmune Bio, Inc. (INMB)vs ›

$49.45M

N/A

3.11%

2.71%

Sensus Healthcare, Inc. (SRTS)vs ›

$49.55M

N/A

11.25%

14.93%

13.84%

Microbot Medical Inc. (MBOT)vs ›

$49.34M

N/A

0.89%

5.54%

4.70%

Dogwood Therapeutics, Inc. (DWTX)vs ›

$49.77M

N/A

Celularity Inc. (CELU)vs ›

$49.79M

N/A

Lite Strategy, Inc. (LITS)vs ›

$48.32M

N/A

Precision Optics Corporation, Inc. (POCI)vs ›

$48.27M

N/A

0.84%

Eloxx Pharmaceuticals, Inc. (ELOX)vs ›

$50.45M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

APLM EBITDA Yield Metrics

APLM Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics